Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

603222.SS Gross Margin

The Gross Margin of Chimin Health Management Co Ltd (603222.SS) is 24.10%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

603222.SS Gross Margin - Historical Value
Date Value
2025-12-31 24.10%
2024-12-31 35.72%
2023-12-31 42.05%
2022-12-31 45.36%
2021-12-31 47.46%
2020-12-31 40.66%
2019-12-31 45.53%
2018-12-31 41.29%
2017-12-31 45.00%
2016-12-31 45.45%
603222.SS Gross Margin - Peers Comparison
Ticker Name Value
300199.SZ Hybio Pharmaceutical Co Ltd 56.41%
688189.SS Hunan Nucien Pharmaceutical Co Ltd 51.05%
002412.SZ Hunan Hansen Pharmaceutical Co Ltd 77.31%
300705.SZ Hunan Jiudian Pharmaceutical Co Ltd 72.71%
600381.SS Qinghai Spring Medicinal Resources Technology Co Ltd 38.50%
002107.SZ Shandong Wohua Pharmaceutical Co Ltd 75.14%
603811.SS Zhejiang Cheng Yi Pharmaceutical Co Ltd 68.88%
688566.SS Jiangsu Jibeier Pharmaceutical Co Ltd 89.38%
002349.SZ Jinghua Pharmaceutical Group Co Ltd 48.67%
300181.SZ Zhejiang Jolly Pharmaceutical Co Ltd 61.25%
300636.SZ Jiangxi Synergy Pharmaceutical Co Ltd 22.75%
002118.SZ Jilin Zixin Pharmaceutical Industrial Co Ltd 58.50%
000908.SZ CSPC Hunan Jingfeng Pharmaceutical Co Ltd 60.87%
002393.SZ Tianjin Lisheng Pharmaceutical Co Ltd 54.11%
605177.SS Zhejiang East Asia Pharmaceutical Co Ltd 16.68%
000790.SZ Chengdu huasun technology group Inc LTD 46.22%
300434.SZ Sichuan Goldstone Asia Pharmaceutical Inc 58.07%
300436.SZ Fujian Cosunter Pharmaceutical Co Ltd 53.90%
300878.SZ Zhejiang Wecome Pharmaceutical Co Ltd 36.39%
603079.SS Zhejiang Shengda Bio-Pharm Co Ltd 24.95%
603590.SS Beijing Konruns Pharmaceutical Co Ltd 89.92%
603676.SS Tibet Weixinkang Pharmaceutical Co Ltd 61.05%
002644.SZ Lanzhou Foci Pharmaceutical Co Ltd 33.90%
605116.SS Aurisco Pharmaceutical Co Ltd 57.22%
300871.SZ Wuhan Hvsen Biotechnology Co Ltd 16.22%
603538.SS Ningbo Menovo Pharmaceutical Co Ltd 32.69%
688513.SS Chengdu Easton Biopharmaceuticals Co Ltd 74.50%
002907.SZ Chongqing Pharscin Pharmaceutical Co Ltd 57.21%